Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Mejia

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
World Journal of Oncology|November 18, 2017
Advanced Thyroid Cancer Patients in Phase I Clinical Trials: Outcome Assessment and Literature ReviewLaeeq Malik, Alex Mejia
Journal of Clinical Medicine Research|April 16, 2014
Informed consent for phase I oncology trials: form, substance and signatureLaeeq Malik, Alex Mejia
Expert Review of Clinical Pharmacology|August 9, 2011
Acid peptic diseases: pharmacological approach to treatmentAlex Mejia, Walter K Kraft
Expert Review of Molecular Diagnostics|September 13, 2008
Previstage GCC test for staging patients with colorectal cancerAlex Mejia, Scott A Waldmana
European Journal of Cancer (Oxford, England : 1990)|September 22, 2014
Eligibility of patients with renal impairment for Phase I trials: Time for a rethink?Laeeq Malik, Alex Mejia, Steven Weitman
Clinical Trials (London, England)|August 20, 2014
How well informed is the informed consent for cancer clinical trials?Laeeq Malik, James Kuo, Desmond Yip, et al.
Journal of Surgical Oncology|March 24, 2012
Molecular staging individualizing cancer managementAlex Mejia, Stephanie Schulz, Terry Hyslop, et al.
Expert Review of Molecular Diagnostics|November 10, 2009
GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patientsAlex Mejia, Stephanie Schulz, Terry Hyslop, et al.
Advances in Clinical Chemistry|February 1, 2011
Molecular staging estimates occult tumor burden in colorectal cancerAlex Mejia, Stephanie Schulz, Terry Hyslop, et al.
Clinical Genitourinary Cancer|March 4, 2014
Clinical outcomes and survival of advanced renal cancer patients in phase I clinical trialsLaeeq Malik, Helen Parsons, Devalingam Mahalingam, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
World Journal of Oncology|November 18, 2017
Advanced Thyroid Cancer Patients in Phase I Clinical Trials: Outcome Assessment and Literature ReviewLaeeq Malik, Alex Mejia
Journal of Clinical Medicine Research|April 16, 2014
Informed consent for phase I oncology trials: form, substance and signatureLaeeq Malik, Alex Mejia
Expert Review of Clinical Pharmacology|August 9, 2011
Acid peptic diseases: pharmacological approach to treatmentAlex Mejia, Walter K Kraft
Expert Review of Molecular Diagnostics|September 13, 2008
Previstage GCC test for staging patients with colorectal cancerAlex Mejia, Scott A Waldmana
European Journal of Cancer (Oxford, England : 1990)|September 22, 2014
Eligibility of patients with renal impairment for Phase I trials: Time for a rethink?Laeeq Malik, Alex Mejia, Steven Weitman
Clinical Trials (London, England)|August 20, 2014
How well informed is the informed consent for cancer clinical trials?Laeeq Malik, James Kuo, Desmond Yip, et al.
Journal of Surgical Oncology|March 24, 2012
Molecular staging individualizing cancer managementAlex Mejia, Stephanie Schulz, Terry Hyslop, et al.
Expert Review of Molecular Diagnostics|November 10, 2009
GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patientsAlex Mejia, Stephanie Schulz, Terry Hyslop, et al.
Advances in Clinical Chemistry|February 1, 2011
Molecular staging estimates occult tumor burden in colorectal cancerAlex Mejia, Stephanie Schulz, Terry Hyslop, et al.
Clinical Genitourinary Cancer|March 4, 2014
Clinical outcomes and survival of advanced renal cancer patients in phase I clinical trialsLaeeq Malik, Helen Parsons, Devalingam Mahalingam, et al.
Pageof 2